论文部分内容阅读
摘要目的对照进展期肝细胞癌(HCC)经动脉化疗栓塞(TACE)与索拉非尼的疗效。材料与方法此项回顾性研究由医院审查委员会批准,符合HIPAA要求,并免除获得知情同意通知的要求。自1999年1月-2009年12月共治疗372例HCC病人。依照巴塞罗那临床肝癌(BCLC)分期标准[Child-Pugh A或B
Abstract Objective To compare the efficacy of transcatheter arterial chemoembolization (TACE) and sorafenib in advanced hepatocellular carcinoma (HCC). Materials and Methods This retrospective study was approved by the hospital review board and met the HIPAA requirements and was exempted from obtaining the informed consent notice. A total of 372 patients with HCC were treated from January 1999 to December 2009. According to Barcelona clinical liver cancer (BCLC) staging criteria [Child-Pugh A or B